Get Professional Valuation and Credit Risk Reports of Any Company in the World
New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →
Get Professional Valuation and Credit Risk Reports of Any Company in the World
- Get an AI-powered company valuation or credit risk report in just 2 minutes
- Get reports of any company in the world with a financial statement in any language
- Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics
Specialty Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 38476599
Parcelvej 11, 2840 Holte
uhs@specialtypharma.dk
tel: 21127210
www.specialtypharma.dk
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 639.30 | 1 023.44 | 292.69 | 96.40 | 216.74 |
| Employee benefit expenses | - 704.77 | - 963.49 | - 183.75 | - 157.05 | - 287.47 |
| EBIT | -65.47 | 59.94 | 108.94 | -60.66 | -70.74 |
| Other financial expenses | -0.50 | -1.70 | -2.49 | -0.36 | |
| Pre-tax profit | -65.97 | 58.24 | 108.94 | -63.14 | -71.10 |
| Income taxes | 21.74 | -17.12 | -28.25 | 9.38 | 12.53 |
| Net earnings | -44.23 | 41.13 | 80.69 | -53.76 | -58.57 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 18.82 | 128.25 | 96.13 | 6.39 | |
| Current deferred tax assets | 21.74 | 2.62 | 9.38 | 21.92 | |
| Short term receivables total | 21.74 | 21.44 | 128.25 | 105.51 | 28.31 |
| Other current investments | 18.00 | 18.00 | 18.00 | ||
| Cash and bank deposits | 101.85 | 94.34 | 34.07 | 34.18 | 39.53 |
| Cash and cash equivalents | 101.85 | 94.34 | 52.07 | 52.18 | 57.53 |
| Balance sheet total (assets) | 123.59 | 115.78 | 180.33 | 157.69 | 85.83 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -33.08 | -77.31 | -36.18 | 44.51 | -9.25 |
| Profit of the financial year | -44.23 | 41.13 | 80.69 | -53.76 | -58.57 |
| Shareholders equity total | -27.31 | 13.82 | 94.51 | 40.75 | -17.82 |
| Non-current liabilities total | |||||
| Short-term deferred tax liabilities | 25.63 | ||||
| Other non-interest bearing current liabilities | 150.90 | 101.96 | 60.19 | 116.94 | 103.65 |
| Current liabilities total | 150.90 | 101.96 | 85.82 | 116.94 | 103.65 |
| Balance sheet total (liabilities) | 123.59 | 115.78 | 180.33 | 157.69 | 85.83 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.